Biohaven’s verdiperstat gets fast-track designation
Biohaven’s myeloperoxidase inhibitor, verdiperstat, has received Fast Track designation from the FDA for the treatment of multiple system atrophy. The FDA’s Fast Track designation provides...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Biohaven’s myeloperoxidase inhibitor, verdiperstat, has received Fast Track designation from the FDA for the treatment of multiple system atrophy. The FDA’s Fast Track designation provides...
Medical manufacturer Medtronic plans to increase its production of ventilators in response to the demands of COVID-19, the disease caused by the novel coronavirus currently...
Due to the COVID-19 crisis, Connecticut Governor Lamont has issued Executive Order No. 7H, which orders restrictions on workplaces for “non-essential” businesses. I have been...
Governor Lamont has applauded The Jackson Laboratory for assisting with COVID-19 testing in Connecticut … more Paulo Verardi’s team at UConn has begun exploring vaccine...
DotLab seeks to make the diagnosis of endometriosis as simple as a blood test. The company came out of stealth last year with an early...
Pfizer has teamed up with BioNTech to co-develop and distribute a mRNA vaccine against COVID-19 outside of China. The partners plan to use multiple R&D...
Arvinas recently announced implementation of a remote work policy intended to minimize the potential of exposure to COVID-19 while maintaining lab-based operations as long as...
Pfizer issued a five-point plan calling on the biopharmaceutical industry to join the company in committing to unprecedented collaboration to combat COVID-19. more
As of March 16, in accordance with guidelines issued by Governor Lamont and the recommendations of the Centers for Disease Control (CDC), BioCT staff are...
Dear BioCT Community, As many companies work to develop diagnostics, vaccines and treatments to address the global COVID-19 outbreak, we want to help all of...